To begin their analysis, researchers highlighted the significant morbidity and mortality caused by RSV in older adults. Complacency, the first C in the 3C Model, was defined by study authors as low perceived risk of vaccine-preventable diseases. Because of the strong focus on the burden of RSV among children, the risk among older adults was overshadowed. The findings highlight the importance of understanding RSV risk among older adults, and aids pharmacists’ awareness when patients are hesitant to receiving the RSV vaccine. ReferenceRSV vaccination in older adults: Addressing vaccine hesitancy using the 3C model.

Source: New York Times March 01, 2024 20:11 UTC